Pfizer releases clinical trial data for COVID-19 vaccine for children aged 5 to 11

Pfizer publicly released data from its coronavirus vaccine trial appearing to show that it's both safe and effective for children aged five to 11. But that data is now being reviewed by regulators, and parents want to carefully weigh the risks.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting